Literature DB >> 8163673

Antibodies to opacity proteins (Opa) correlate with a reduced risk of gonococcal salpingitis.

F A Plummer1, H Chubb, J N Simonsen, M Bosire, L Slaney, N J Nagelkerke, I Maclean, J O Ndinya-Achola, P Waiyaki, R C Brunham.   

Abstract

Acute salpingitis complicating cervical gonococcal infection is a significant cause of infertility. Relatively little data are available concerning the pathophysiologic mechanisms of this disease. A cohort of 243 prostitutes residing in Nairobi were followed between March 1985 and April 1988. Gonococcal cultures were performed at each visit, and acute salpingitis was diagnosed clinically. Serum at enrollment was tested by immunoblot for antibody to gonococcal outer membrane proteins. 8.6% (146/1689) of gonococcal infections were complicated by salpingitis. Increased risk of salpingitis was associated with younger age, shorter duration of prostitution, HIV infection, number of gonococcal infections, and episodes of nongonococcal salpingitis. Rmp antibody increased the risk of salpingitis. Antibody to Opa decreased the risk of salpingitis. By logistic regression analysis, antibody to Opa was independently associated with decreased risk of gonococcal salpingitis (adjusted odds ratio [OR], 0.35; 95% confidence interval [95%CI], 0.17-0.76); HIV infection (adjusted OR, 3.5; 95% CI, 0.96-12.8) and episodes of nongonococcal salpingitis (adjusted OR, 3.4; 95% CI, 1.8-6.4) were independently associated with an increased risk of salpingitis. Antibody to Opa appears to protect against ascending gonococcal infection, perhaps by interfering with Opa mediated adherence and endocytosis. The demonstration of natural immunity that protects against upper genital tract infection in women suggests that a vaccine to prevent gonococcal salpingitis is possible.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8163673      PMCID: PMC294233          DOI: 10.1172/JCI117159

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  Variations in surface protein composition associated with virulence properties in opacity types of Neisseria gonorrhoeae.

Authors:  P R Lambden; J E Heckels; L T James; P J Watt
Journal:  J Gen Microbiol       Date:  1979-10

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Antigenic variation during infection with Neisseria gonorrhoeae: detection of antibodies to surface proteins in sera of patients with gonorrhea.

Authors:  K Zak; J L Diaz; D Jackson; J E Heckels
Journal:  J Infect Dis       Date:  1984-02       Impact factor: 5.226

4.  Rates in vitro changes of gonococcal colony opacity phenotypes.

Authors:  L W Mayer
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

5.  Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I.

Authors:  J S Knapp; M R Tam; R C Nowinski; K K Holmes; E G Sandström
Journal:  J Infect Dis       Date:  1984-07       Impact factor: 5.226

6.  Relation of protein I and colony opacity to serum killing of Neisseria gonorrhoeae.

Authors:  J F James; E Zurlinden; C J Lammel; G F Brooks
Journal:  J Infect Dis       Date:  1982-01       Impact factor: 5.226

7.  Comparison of virulence markers of peritoneal and fallopian tube isolates with endocervical Neisseria gonorrhoeae isolates from women with acute salpingitis.

Authors:  D L Draper; J F James; G F Brooks; R L Sweet
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

8.  Pathogenic mechanisms of Neisseria gonorrhoeae: observations on damage to human fallopian tubes in organ culture by gonococci of colony type 1 or type 4.

Authors:  Z A McGee; A P Johnson; D Taylor-Robinson
Journal:  J Infect Dis       Date:  1981-03       Impact factor: 5.226

9.  Gonococcal salpingitis is less likely to recur with Neisseria gonorrhoeae of the same principal outer membrane protein antigenic type.

Authors:  T M Buchanan; D A Eschenbach; J S Knapp; K K Holmes
Journal:  Am J Obstet Gynecol       Date:  1980-12-01       Impact factor: 8.661

10.  Antibody to Rmp (outer membrane protein 3) increases susceptibility to gonococcal infection.

Authors:  F A Plummer; H Chubb; J N Simonsen; M Bosire; L Slaney; I Maclean; J O Ndinya-Achola; P Waiyaki; R C Brunham
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

View more
  23 in total

1.  The oligosaccharide of gonococcal lipooligosaccharide contains several epitopes that are recognized by human antibodies.

Authors:  Ryohei Yamasaki; Uichirou Yabe; Chikako Kataoka; Ushio Takeda; Shunpei Asuka
Journal:  Infect Immun       Date:  2010-05-17       Impact factor: 3.441

2.  Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination.

Authors:  K Eriksson; M Quiding-Järbrink; J Osek; A Möller; S Björk; J Holmgren; C Czerkinsky
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

3.  Properdin is critical for antibody-dependent bactericidal activity against Neisseria gonorrhoeae that recruit C4b-binding protein.

Authors:  Sunita Gulati; Sarika Agarwal; Shreekant Vasudhev; Peter A Rice; Sanjay Ram
Journal:  J Immunol       Date:  2012-02-24       Impact factor: 5.422

4.  CGM1a antigen of neutrophils, a receptor of gonococcal opacity proteins.

Authors:  T Chen; E C Gotschlich
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

5.  The gonococcal Fur-regulated tbpA and tbpB genes are expressed during natural mucosal gonococcal infection.

Authors:  Sarika Agarwal; Carol A King; Ellen K Klein; David E Soper; Peter A Rice; Lee M Wetzler; Caroline A Genco
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

6.  Regulatory T cells are locally induced during intravaginal infection of mice with Neisseria gonorrhoeae.

Authors:  Mónica Imarai; Enzo Candia; Carolina Rodriguez-Tirado; Javier Tognarelli; Mirka Pardo; Tomas Pérez; Daniel Valdés; Sebastián Reyes-Cerpa; Pablo Nelson; Claudio Acuna-Castillo; Kevin Maisey
Journal:  Infect Immun       Date:  2008-09-29       Impact factor: 3.441

Review 7.  Dendritic cells and vaccine design for sexually-transmitted diseases.

Authors:  Dorothee Duluc; Julien Gannevat; Hyemee Joo; Ling Ni; Katherine Upchurch; Muriel Boreham; Michael Carley; Jack Stecher; Gerard Zurawski; Sangkon Oh
Journal:  Microb Pathog       Date:  2012-11-29       Impact factor: 3.738

8.  Immunogenetic correlates of Neisseria gonorrhoeae infection in adolescents.

Authors:  William M Geisler; Chengbin Wang; Jianming Tang; Craig M Wilson; Peggy A Crowley-Nowick; Richard A Kaslow
Journal:  Sex Transm Dis       Date:  2008-07       Impact factor: 2.830

Review 9.  Summary and Recommendations from the National Institute of Allergy and Infectious Diseases (NIAID) Workshop "Gonorrhea Vaccines: the Way Forward".

Authors:  Lee M Wetzler; Ian M Feavers; Scott D Gray-Owen; Ann E Jerse; Peter A Rice; Carolyn D Deal
Journal:  Clin Vaccine Immunol       Date:  2016-08-05

10.  Functional characterization of antibodies against Neisseria gonorrhoeae opacity protein loops.

Authors:  Jessica G Cole; Ann E Jerse
Journal:  PLoS One       Date:  2009-12-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.